Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

November 30, 2023 20:24 (London Time)

Sanofi

Youtube Subscribe

...

Sector: Pharmaceuticals
Ticker: SNY
Sentiment: 0.936
MarketCap: 117,101,841,858.0
High: 46.74 Low: 46.0

Open: 46.12 Close: 46.65 Change: 0.53

You'll be sorry if you don't use an AI to decide whether to invest in Sanofi.

Are looking for the most relevant information about Sanofi? Investor spend a lot of time searching for information to make investment decisions in Sanofi. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Sanofi are: Sanofi, Ltd, global, Sanofis, environment, Regeneron, file, and the most common words in the summary are: sanofi, trial, bloomberg, company, news, data, drug, . One of the sentences in the summary was: Sanofi Bangladesh Ltd signed the acquisition deal with Beximco Pharma. Other searches related to …

Concept Map

...

Semantic Network

...

Stock Summary

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company also provides cough, cold.

Today's Summary

Sanofi Bangladesh Ltd signed the acquisition deal with Beximco Pharma. Bangladeshi pharmaceutical company will take over the shares from Fisons Ltd and May and Baker Ltd of the UK – the two foreign shareholders of Sanofi.

Today's News

Sanofi (SNW.F) stock price, news, quote & history - yahoo finance. Sanofi is a global integrated healthcare leader focused on patients needs. Sanofi launches 2023 global Employee Stock Purchase Plan. Scribe Therapeutics Expands Collaboration with Sanofi to Advance In Vivo Genetic Medicines for Sickle Cell and Other Genomic Diseases. Search Houston Jobs at Sanofi. Sanofis Postdoctoral Program helps you advance your scientific career in a state-of-the-art environment. Sanofi and Regeneron plan year-end filing in COPD Nov. and Sanofi SA will file a supplemental BLA for Dupixent (dupilumab) in chronic obstructive pulmonary disease (COPD) The drug is jointly developed by Regeneron and Sanofis. Sanofi Bangladesh Ltd signed the acquisition deal with Beximco Pharma. Bangladeshi pharmaceutical company will take over the shares from Fisons Ltd and May and Baker Ltd of the UK – the two foreign shareholders of Sanofi. The two UK-based firms hold 19.63 lakh Sanofi shares, each at Tk2,445. Sanofi CEO Hudson said he was “inspired” by McLaren’s culture of continuous incremental improvement in the pressure-cooker F1 environment. The asthma injection showed strong efficacy in a second final-stage study of people with chronic obstructive pulmonary disease.

Stock Profile

"Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as dupixent, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers body lotions, anti-itch products, moisturizing and soothing lotions, body and foot creams, and eczema powders. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for Parkinson's disease; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Amunix Pharmaceuticals, Inc for T-cell engagers and cytokine therapies. It also enters in a strategic collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France."

Keywords

How much time have you spent trying to decide whether investing in Sanofi? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Sanofi are: Sanofi, Ltd, global, Sanofis, environment, Regeneron, file, and the most common words in the summary are: sanofi, trial, bloomberg, company, news, data, drug, . One of the sentences in the summary was: Sanofi Bangladesh Ltd signed the acquisition deal with Beximco Pharma. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #sanofi #trial #bloomberg #company #news #data #drug.

Read more →

Related Results

...
March 09, 2024 7:34 (London Time)

Sanofi

Sanofi SA (EPA: SAN) is gaining at writing following a report that buyout firms have shown interest in buying its consumer health unit. Fluzone® Hig…
Sector: Pharmaceuticals
Ticker: SNY
Sentiment: 0.9758
MarketCap: 120,306,669,364.0
High: 48.25 Low: 47.98

Open: 47.99 Close: 48.25 Change: 0.26

Read more →
...
February 03, 2024 23:13 (London Time)

Sanofi

Sanofi and manufacturing partner AstraZeneca have announced a new reservation program to address the shortages of the respiratory syncytial virus va…
Sector: Pharmaceuticals
Ticker: SNY
Sentiment: 0.7003
MarketCap: 119,160,210,446.0
High: 48.04 Low: 47.2

Open: 48.0 Close: 47.23 Change: -0.77

Read more →
...
January 10, 2024 18:53 (London Time)

Sanofi

Sanofi established a $35 monthly cap on out-of-pocket costs for Lantus, its most widely prescribed insulin in the US, for all patients with commerci…
Sector: Pharmaceuticals
Ticker: SNY
Sentiment: 0.9776
MarketCap: 130,699,312,683.0
High: 52.25 Low: 51.91

Open: 51.93 Close: 52.06 Change: 0.13

Read more →
...
December 26, 2023 21:17 (London Time)

Sanofi

Kymera Therapeutics continues to cash in on its up-to-$2 billion collaboration with Sanofi. Exscientia plc announced a new discovery stage programme…
Sector: Pharmaceuticals
Ticker: SNY
Sentiment: -0.9531
MarketCap: 123,291,032,661.0
High: 49.19 Low: 48.59

Open: 48.71 Close: 49.08 Change: 0.37

Read more →
...
December 17, 2023 21:42 (London Time)

Sanofi

French drugmaker cancels deal to license Maze Therapeutics Inc. Maze alleges the transaction would protect Sanofis. monopoly. Maze was to get an upf…
Sector: Pharmaceuticals
Ticker: SNY
Sentiment: 0.8402
MarketCap: 120,886,628,976.0
High: 48.12 Low: 47.46

Open: 47.94 Close: 47.68 Change: -0.26

Read more →
...
November 22, 2023 22:21 (London Time)

Sanofi

French drugmaker Sanofi fell as much as 16% on Friday after hiking its research-and-development expense guidance. CDC expedites release of more dose…
Sector: Pharmaceuticals
Ticker: SNY
Sentiment: 0.9678
MarketCap: 117,121,016,786.0
High: 46.49 Low: 46.11

Open: 46.4 Close: 46.46 Change: 0.06

Read more →
...
October 02, 2023 0:07 (London Time)

Sanofi

Sanofi is best known for the prescription sleeping pill Ambien and Admelog, a fast-acting mealtime insulin.
Sector: Pharmaceuticals
Ticker: SNY
Sentiment: 0.9584
MarketCap: 134,368,697,221.0
High: 53.97 Low: 53.43

Open: 53.95 Close: 53.64 Change: -0.31

Read more →
...
September 25, 2023 15:03 (London Time)

Sanofi

Sanofi plans to invest over EUR 450 million through 2030. Sanofi struck a $5.2 billion deal with Exscientia, a cancer biotech; made a $1.2bn deal wi…
Sector: Pharmaceuticals
Ticker: SNY
Sentiment: -0.3818
MarketCap: 136,450,252,545.0
High: 54.3 Low: 53.99

Open: 54.16 Close: 54.15 Change: -0.01

Read more →
...
September 02, 2023 1:54 (London Time)

Sanofi

U.S. Senators Maggie Hassan (D-NH) and Tina Smith pressed three major insulin manufacturers, Eli Lilly, Novo Nordisk, and Sanofi. Sanofi generated n…
Sector: Pharmaceuticals
Ticker: SNY
Sentiment: 0.966
MarketCap: 135,141,866,137.0
High: 53.92 Low: 52.99

Open: 53.88 Close: 53.13 Change: -0.75

Read more →
...
August 20, 2023 12:49 (London Time)

Sanofi

Sanofi SA ended the second quarter with a small 1.5% decline in net sales to €9.965 billion. Sanofi bid $172 on July 27, just below Biogens offer of…
Sector: Pharmaceuticals
Ticker: SNY
Sentiment: 0.8555
MarketCap: 133,595,605,421.0
High: 53.38 Low: 53.08

Open: 53.11 Close: 53.25 Change: 0.14

Read more →
...
August 05, 2023 9:08 (London Time)

Sanofi

French drugmaker Sanofi increased its guidance for full-year earnings on strong sales of anti-inflammatory treatment Dupixent. Sanofi CEO Paul Hudso…
Sector: Pharmaceuticals
Ticker: SNY
Sentiment: 0.9862
MarketCap: 133,144,168,486.0
High: 51.91 Low: 51.35

Open: 51.37 Close: 51.65 Change: 0.28

Read more →
...
July 24, 2023 12:10 (London Time)

Sanofi

Sanofi closed at $53.67, marking a +0.36% move from the previous day. European Central Bank expected to announce a 25-basel point rate hike on Thurs…
Sector: Pharmaceuticals
Ticker: SNY
Sentiment: 0.9806
MarketCap: 137,261,401,881.0
High: 54.97 Low: 54.63

Open: 54.92 Close: 54.95 Change: 0.03

Read more →
...
June 04, 2023 16:30 (London Time)

Sanofi

French healthcare company Sanofi plans to initiate pivotal trials in multiple sclerosis in early 2024. Sanofi SA has fallen 5.96% over the past mont…
Sector: Pharmaceuticals
Ticker: SNY
Sentiment: 0.9701
MarketCap: 137,755,438,157.0
High: 51.03 Low: 50.65

Open: 50.69 Close: 51.01 Change: 0.32

Read more →
...
May 18, 2023 20:59 (London Time)

Sanofi

Sanofi Restates 4Q, Full-Year 2022 Profit on Hemophilia Treatment Approval. Sanofis Lantus - $400 per 5-pen package - whilst making the unbranded ~6…
Sector: Pharmaceuticals
Ticker: SNY
Sentiment: 0.9875
MarketCap: 137,755,438,157.0
High: 53.94 Low: 53.41

Open: 53.92 Close: 53.86 Change: -0.06

Read more →
...
May 02, 2023 6:44 (London Time)

Sanofi

French drugmaker Sanofi posts better-than-expected earnings for first quarter. Dupixent was successfully tested last month to treat smokers lung or …
Sector: Pharmaceuticals
Ticker: SNY
Sentiment: 0.9949
MarketCap: 139,862,097,920
High: 53.96 Low: 53.39

Open: 53.91 Close: 53.44 Change: -0.47

Read more →
...
April 30, 2023 12:08 (London Time)

Sanofi

French drugmaker Sanofi posted better-than-expected earnings for the first quarter. Dupixent sales offset declining sales from established MS pill A…
Sector: Pharmaceuticals
Ticker: SNY
Sentiment: 0.9712
MarketCap: 140,411,699,200
High: 55.32 Low: 53.46

Open: 54.8 Close: 53.65 Change: -1.15

Read more →
...
March 04, 2024 10:18 (London Time)

Sanofi

Sanofi S.A. was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélélabos. In 2004, Sanofi merged with Aventis and renamed…
Sector: Pharmaceuticals
Ticker: SNY
Sentiment: 0.9843
MarketCap: 117,774,968,542.0
High: 47.5 Low: 47.08

Open: 47.44 Close: 47.29 Change: -0.15

Read more →
...
January 17, 2024 1:48 (London Time)

Sanofi

UBS analyst Jo Walton upgraded Sanofi ( SNYNF – Research Report ) to a Buy today and set a price target of €110.00. Jefferies Reaffirms Their Buy Ra…
Sector: Pharmaceuticals
Ticker: SNY
Sentiment: 0.8074
MarketCap: 131,700,232,391.0
High: 52.0 Low: 51.5

Open: 51.75 Close: 51.56 Change: -0.19

Read more →
...
January 02, 2024 12:45 (London Time)

Sanofi

Pfizer, Sanofi and Takeda Pharmaceutical are due to raise prices on more than 500 drugs in the US from January. Sanofi established a $35 monthly cap…
Sector: Pharmaceuticals
Ticker: SNY
Sentiment: -0.6705
MarketCap: 124,550,397,372.0
High: 49.89 Low: 49.44

Open: 49.56 Close: 49.73 Change: 0.17

Read more →
...
December 25, 2023 19:39 (London Time)

Sanofi

Sanofi to end tusamitamab ravtansine development after trial failure. Pfizer, GSK, Sanofi and Biogen have each tapped local partners to help commerc…
Sector: Pharmaceuticals
Ticker: SNY
Sentiment: -0.8885
MarketCap: 123,291,032,661.0
High: 49.43 Low: 48.7

Open: 49.17 Close: 48.74 Change: -0.43

Read more →
...
November 30, 2023 20:24 (London Time)

Sanofi

Sanofi Bangladesh Ltd signed the acquisition deal with Beximco Pharma. Bangladeshi pharmaceutical company will take over the shares from Fisons Ltd …
Sector: Pharmaceuticals
Ticker: SNY
Sentiment: 0.936
MarketCap: 117,101,841,858.0
High: 46.74 Low: 46.0

Open: 46.12 Close: 46.65 Change: 0.53

Read more →
...
November 12, 2023 5:12 (London Time)

Sanofi

French prosecutors probing Sanofi over possible market manipulation. Sanofi shares were down by as much as 2% midday on Tuesday. The pharmaceutical …
Sector: Pharmaceuticals
Ticker: SNY
Sentiment: 0.7783
MarketCap: 113,875,938,046.0
High: 46.14 Low: 45.32

Open: 46.08 Close: 45.92 Change: -0.16

Read more →
...
September 26, 2023 14:01 (London Time)

Sanofi

Sanofi CEO Paul Hudson: We want to be the first-scale pharmaceutical company. Dupixent received FDA approval for treating EoE in individuals aged 12…
Sector: Pharmaceuticals
Ticker: SNY
Sentiment: 0.9705
MarketCap: 136,984,129,982.0
High: 54.32 Low: 54.14

Open: 54.17 Close: 54.21 Change: 0.04

Read more →
...
September 24, 2023 13:03 (London Time)

Sanofi

French pharmaceutical giant, Sanofi (NASDAQ:SNY) has forecasted a substantial impact on its third-quarter sales and business earnings per share due …
Sector: Pharmaceuticals
Ticker: SNY
Sentiment: 0.872
MarketCap: 136,865,329,995.0
High: 54.44 Low: 54.02

Open: 54.12 Close: 54.02 Change: -0.1

Read more →
...
August 21, 2023 18:25 (London Time)

Sanofi

Grove Bank & Trust increased its stake in Sanofi by 129.3% in the first quarter. Grove Bank and Trust also received an annual dividend from the comp…
Sector: Pharmaceuticals
Ticker: SNY
Sentiment: 0.9666
MarketCap: 133,595,605,421.0
High: 53.81 Low: 53.53

Open: 53.64 Close: 53.75 Change: 0.11

Read more →
...
August 19, 2023 21:24 (London Time)

Sanofi

Rilzabrutinib was under development for the treatment of pemphigus foliaceus, newly diagnosed or relapsing pemphyus vulgaris. Sanofi Bangladesh Ltd …
Sector: Pharmaceuticals
Ticker: SNY
Sentiment: 0.8271
MarketCap: 133,595,605,421.0
High: 53.38 Low: 53.08

Open: 53.11 Close: 53.25 Change: 0.14

Read more →
...
July 28, 2023 0:54 (London Time)

Sanofi

Sanofi-Aventis SA, the worlds fourth-biggest drugmaker, said Friday it is eliminating 1,700 jobs in its U.S. pharmaceutical business. FDA approves S…
Sector: Pharmaceuticals
Ticker: SNY
Sentiment: 0.8165
MarketCap: 133,550,281,917.0
High: 53.92 Low: 53.51

Open: 53.59 Close: 53.54 Change: -0.05

Read more →
...
July 13, 2023 19:46 (London Time)

Sanofi

Innate Pharma (NASDAQ: IPHA) was up 8% Thursday morning after rising as much as 10.6% earlier in the day. Sanofi closed at $53.67, marking a +0.36% …
Sector: Pharmaceuticals
Ticker: SNY
Sentiment: 0.959
MarketCap: 128,931,604,150.0
High: 52.61 Low: 51.92

Open: 52.61 Close: 52.12 Change: -0.49

Read more →
...
May 25, 2023 23:01 (London Time)

Sanofi

U.S. Supreme Court rules against Amgen in cholesterol drug patent dispute with sanofi. The contentious battle is centred around two monoclonal antib…
Sector: Pharmaceuticals
Ticker: SNY
Sentiment: 0.9516
MarketCap: 137,755,438,157.0
High: 53.32 Low: 52.17

Open: 53.32 Close: 52.59 Change: -0.73

Read more →
...
May 17, 2023 8:44 (London Time)

Sanofi

Wall Street analysts say Sanofi is currently Undervalued. Wall Street analyst and broker recommendations for Sanofi are Buy.
Sector: Pharmaceuticals
Ticker: SNY
Sentiment: 0.9921
MarketCap: 137,755,438,157.0
High: 54.72 Low: 54.1

Open: 54.24 Close: 54.55 Change: 0.31

Read more →
...
May 01, 2023 23:29 (London Time)

Sanofi

French drugmaker Sanofi posted better-than-expected earnings for the first quarter. Dupixent sales beat consensus, helped offset declining sales fro…
Sector: Pharmaceuticals
Ticker: SNY
Sentiment: 0.9839
MarketCap: 139,862,097,920
High: 53.96 Low: 53.39

Open: 53.91 Close: 53.44 Change: -0.47

Read more →